Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

59th Meeting of the Clinical Trials and Translational Research Advisory Committee - Meeting Agenda

Wednesday, March 18, 2026

Time: 8:30 AM to 3:00 PM EDT
NIH Videocast: https://videocast.nih.gov/watch/6e20485a-0cff-11f1-9f14-124f0a52e769

Location: NCI Shady Grove
East Wing, Terrace Level
Conference Room TE406/408/410
9609 Medical Center Drive, Rockville, MD  20850

For official meeting slides, please contact Tawny Clark Morton (tclark@emmes.com) or Dr. Sheila Prindiville (prindivs@mail.nih.gov).

Agenda - Open Session
TimePresentation TopicPresenter
8:30 am - 8:35 am            Call to Order and Opening RemarksDr. Vose
8:35 am - 9:15 amNCI Director's ReportDr. Letai
9:15 am - 10:00 amNCI Cancer Screening Trials
  • Implementation Update: CTAC Cancer Screening Trials Working Group Recommendations
Dr. Heckman-Stoddard
  • Five- or Ten-Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps (FORTE)
Dr. Schoen
10:00 am - 10:15 amBreak
10:15 am - 11:30 amOptimizing Electronic Health Records (EHRs) to Support Clinical Trials
  • Introduction 
Dr. Doroshow
  • Accelerating Electronic Clinical Trial Activation Pilot
Dr. Yao
  • Automated EHR Data Extraction & Curation Using ExtractEHR
Dr. Miller
11:30 am - 12:00 pmNCI Cancer Information Service (CIS)Dr. Vanderpool
12:00 pm - 1:00 pmLunch
1:00 pm - 2:10 pmFacilitating Clinical Trials Enrollment
  • NCI's Virtual Clinical Trials Office (VCTO): Update
Dr. Doroshow
  • Decentralized Clinical Trials: The Veterans Health Administration Experience
Dr. Friedman
2:10 pm - 2:45 pmRadiation Oncology-Biology Integration Network (ROBIN)Dr. Buchsbaum
2:45 pm - 3:00 pmOngoing & New Business

Dr. Vose

Dr. Prindiville

3:00 pmAdjourn
  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “59th Meeting of the Clinical Trials and Translational Research Advisory Committee - Meeting Agenda was originally published by the National Cancer Institute.”

Email